1 (800) 463-1008 (Canada) or (908) 852-2311 (USA)

Press Releases

Biocia conducts a robust and ongoing collaboration with leading international medical companies, independent research institutes and individual innovators in North America, Israel, Europe and Asia in the development of medical devices and drugs. As of today, Biocia has executed significant research alliances as well as joint R&D ventures.

We welcome medical companies, research institutes and innovators to make contact with us for information and collaborative opportunities .

 
 
 
Biocia innovation is approved for commercialization by Regulatory Authorities
Dec 20, 2019

December 20, 2019 Biocia Inc. Port Murray, New Jersey, USA— Biocia Inc. (Biocia) (www.BIOCIA.c…

Read More

Biocia & Sam Poong Target – High Volume but Unsatisfied Global Nasal Market
Mar 15, 2016

March 15, 2016 Biocia Inc. (Biocia) (www.BIOCIA.com), a privately owned New Jersey-based biotechnolo…

Read More

Biocia Inc. & I-MED Pharma Inc. align with Sam Poong Fine Chem. Co., Ltd. in Korea
Aug 05, 2015

July 31, 2015 Biocia Inc. (Biocia), a New Jersey-based biotechnology company announced a long term d…

Read More

BIOCIA INNOVATION LEADS EYEDROP MARKET in 2015
Mar 16, 2015

Biocia Inc., a New Jersey-based biotechnology company announced the recent commercialization of thei…

Read More

I-MED Approvals By Health Canada
Oct 30, 2013

I-MED Pharma Inc., a Montreal-based biotechnology company and Biocia Inc., a New Jersey-based biotec…

Read More

Biocia and I-MED Pharma Consummate a Long-Term R&D Agreement With Matrix Biology Institute
Feb 13, 2013

Biocia Inc. and I-MED Pharma Inc. have strengthen their foothold in global ophthalmic eye markets wi…

Read More